Dr. Neville Rohinton Dossabhoy, MD

Dr. Dossabhoy practices at University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning.

Dr. Dossabhoy's NPI, 1811915754, was assigned on July 18, 2006. Dr. Dossabhoy holds Louisiana license 14823R.

Dr. Dossabhoy's primary practice is University of Mississippi Medical Center, at 2500 N State St, Jackson, MS 39216 in Hinds County. The practice phone is (601) 984-4100.

Dr. Dossabhoy's primary practice is University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning. The medical group on file is University of Mississippi Medical Center. Dmand AI also links Dr. Dossabhoy to 1 more behavioral health center, 1 dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Dossabhoy's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dossabhoy practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Dossabhoy's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Dossabhoy is licensed in Louisiana.

CMS data shows 180 Medicare services from Dr. Dossabhoy across 5 procedure codes in 2024, for 88 Medicare patients. Medicare paid $10,458 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 88 Medicare patients who saw Dr. Dossabhoy in 2024. The largest group is under 65, with 38 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 50% are also on Medicaid. Their average risk score is 6.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dossabhoy's median patient age at 61, with 57% women.

In 2024, Dr. Dossabhoy wrote 123 Medicare Part D claims for 28 patients. 83% of them were for generic drugs. CMS names the drug for 48 of them, across 3 drugs with 11 or more claims each, at $10,781 in total drug cost. In 2023, CMS named 33 claims across 3 drugs.

Dr. Dossabhoy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 122 general payments to Dr. Dossabhoy from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. Travere Therapeutics, Inc. paid the most, $11,108.